• Immunohistochemistry analysis of paraffin-embedded human brain tissue, using GPR85 Antibody. The picture on the right is blocked with the synthesized peptide.
  • Immunofluorescence analysis of LOVO cells, using GPR85 Antibody. The picture on the right is blocked with the synthesized peptide.

Anti-GPR85 antibody (181-230 aa) (STJ93398)

SKU:
STJ93398

Current Stock:
Host: Rabbit
Applications: IHC/IF/ELISA
Reactivity: Human/Mouse/Rat
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description: Rabbit polyclonal antibody anti-Probable G-protein coupled receptor 85 (181-230 aa) is suitable for use in Immunohistochemistry, Immunofluorescence and ELISA research applications.
Clonality: Polyclonal
Conjugation: Unconjugated
Isotype: IgG
Formulation: Liquid in PBS containing 50% Glycerol, 0.5% BSA and 0.02% Sodium Azide.
Purification: The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
Concentration: 1 mg/mL
Dilution Range: IHC 1:100-1:300
IF 1:200-1:1000
ELISA 1:10000
Storage Instruction: Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles.
Gene Symbol: GPR85
Gene ID: 54329
Uniprot ID: GPR85_HUMAN
Immunogen Region: 181-230 aa
Specificity: GPR85 Polyclonal Antibody detects endogenous levels of GPR85 protein.
Immunogen: The antiserum was produced against synthesized peptide derived from the human GPR85 at the amino acid range 181-230
Function Orphan receptor.
Protein Name Probable G-Protein Coupled Receptor 85
Super Conserved Receptor Expressed In Brain 2
Cellular Localisation Cell Membrane
Multi-Pass Membrane Protein
Endoplasmic Reticulum
Alternative Antibody Names Anti-Probable G-Protein Coupled Receptor 85 antibody
Anti-Super Conserved Receptor Expressed In Brain 2 antibody
Anti-GPR85 antibody
Anti-SREB2 antibody

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance